Indeed, the evidence of older age, genotype 3, the presence of diabetes, low albumin level and platelet count, and relapse of viremia after DAA therapy remain important parameters independently associated with higher HCC incidence risk [14,19]. The gene discussed is ALB; the disease is hepatocellular carcinoma.